Skip to main content
Wolfson Institute of Preventive Medicine - Barts and The London

CCP to be strongly represented at HPV 2015

news image
The CCP team are excited to be contributing several presentations at the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015) to be held in Lisbon, Portugal on 17-21st September 2015.  The conference is the premiere international event for sharing the latest research and information on HPV, a pathogenic virus that infects hundreds of millions of people worldwide.
Professor Jack Cuzick, Director of the Centre, will give two oral presentations; the first entitled HPV testing in cervical cancer screening on 17th September; the second on HPV triage of ASC-US cytology – utilisation and impact on 5 year CIN rate in New Mexico, USA on 20th September.
Professor Attila Lorincz, who leads the Molecular Epidemiology Laboratory, will give an oral presentation on 19th September entitled Validation of a DNA methylation classifier and comparison to HPV16/18 genotyping in a UK screening population.
Dr Caroline Reuter, Senior Scientific Officer in the Molecular Epidemiology Laboratory, will present on Molecular mapping of complex cervical precancerous lesions using HPV typing and DNA methylation on 18th September.
A former MSc student in the Molecular Epidemiology Laboratory, Rubi Gisela Hernandez, will give an oral presentation entitled Genome Methylation of HPV16, 18, 31, 33 and human genes as a predictor of CIN2+ in HrHPV positive women on 18th September.
Dr Alejandra Castanon, an Epidemiologist in the Cancer Screening & Statistics team, will give two oral presentations: The first on Stage-based mortality impact of cervical screening; and the second on Adenocarcinoma of the cervix: is cervical screening preventing these cancers?Both talks will be on 18th September.
Dr Karly Louie, a Senior Epidemiologist on a Cancer Research UK Population Research Postdoctoral Fellowship, will give an oral presentation entitled: Multiple sampling for human papillomavirus (HPV) detection in the oropharynx among patients undergoing tonsillectomy on 21st September.
The CCP team will also have six posters on display in the Exhibition Area:
Association of DNA methylation of EPB41L3 human gene with CIN2+ and HIV-related factors in African women living with HIV (Helen Kelly – Visiting Lecturer).
Dried blood spot and oral mucosal transudate vs venous blood sera to confirm human papillomavirus (HPV) vaccination status (Dr Karly Louie, Senior Epidemiologist).
Acceptability of four sampling methods for the detection of oral HPV DNA (Dr Karly Louie, Senior Epidemiologist).
Perceived risk and oral HPV infection in high risk adults: analysis of gum clinic attendees in the UK (Dr Karly Louie, Senior Epidemiologist).
Targeting cervical screening non-attenders opportunistically in primary care to offer self-sampling for HPV testing (Dr Anita Lim – Senior Epidemiologist, Cancer Screening & Statistics team).
Lectins: A more objective tool for visual inspection? (Dr Anita Lim – Senior Epidemiologist, Cancer Screening & Statistics team).